2024 FDA Broad Agency Announcement Day Agenda
2024 FDA Broad Agency Announcement Day
November 14, 2024, 1:00 p.m. - 4:00 p.m. EST
Agenda
All times are Eastern Standard Time. Please see the event page for additional information.
| Time | Agenda item | Presenter |
| 1:00 p.m. |
Welcome and Opening Remarks # FDA Regulatory Science Framework and an overview of the new BAA Announcement |
Ms. Shaila Shaheed, ORES Mr. Ian Weiss, OAGS |
| 1:10 p.m. |
FY 2025 FDA Funding Priorities * # BsUFA III Research Priorities # Rare Diseases Research Priorities # CDRH Highlighted Research Areas of Interest # Medical Countermeasures Initiative Research Priorities # Oncology Research Priorities # CVM Research Priorities # One Health Research Priorities # Women's Health Research Priorities BAA Application Overview # Application Process and Requirements # Award Process and Requirements Question and Answer Panel # Review of questions submitted via webinar Q&A pod, and in advance to FDABAA@fda.hhs.gov |
Dr. Darlese Solorzano, CDER Dr. Bridget Nugent, CDER Dr. Michele Lee, CDRH Dr. Robert Orr, ORES Dr. Rebekah Zinn, OCE Ms. Sara Sklenka, CVM CAPT Brianna Skinner, ORES Dr. Joyce Obidi, OWH
Dr. Kinnera Chada, ORES Mr. Ian Weiss, OAGS
Panel Members: ORES & OAGS |
| 3:55 p.m. | Adjourn and Closing Remarks | |
* Each presentation will be followed by a 5-minute Q&A. |
||
Note: Recording of the full event (including closed captioning and an audio transcript, presentation slides, and responses to all questions will be posted on the event page.
Acronyms
CDER - Center for Drug Evaluation and Research
CDRH - Center for Devices and Radiological Health
CVM - Center for Veterinary Medicine
OAGS - Office of Acquisitions and Grants Services
OCE - Oncology Center of Excellence
ORES - Office of Regulatory and Emerging Science
OWH - Office of Women’s Health
Back to the event page